Juha K Rantala
Juha K Rantala
Verified email at sheffield.ac.uk - Homepage
Title
Cited by
Cited by
Year
Break-induced replication repair of damaged forks induces genomic duplications in human cells
L Costantino, SK Sotiriou, JK Rantala, S Magin, E Mladenov, T Helleday, ...
Science 343 (6166), 88-91, 2014
3552014
FZD4 as a mediator of ERG oncogene–induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells
S Gupta, K Iljin, H Sara, JP Mpindi, T Mirtti, P Vainio, J Rantala, K Alanen, ...
Cancer research 70 (17), 6735-6745, 2010
2602010
SHARPIN is an endogenous inhibitor of β1-integrin activation
JK Rantala, J Pouwels, T Pellinen, S Veltel, P Laasola, E Mattila, ...
Nature cell biology 13 (11), 1315-1324, 2011
2062011
Integrin trafficking regulated by Rab21 is necessary for cytokinesis
T Pellinen, S Tuomi, A Arjonen, M Wolf, H Edgren, H Meyer, R Grosse, ...
Developmental cell 15 (3), 371-385, 2008
1952008
MiR-9,-31, and-182 deregulation promote proliferation and tumor cell survival in colon cancer
L Cekaite, JK Rantala, J Bruun, M Guriby, TH Ågesen, SA Danielsen, ...
Neoplasia 14 (9), 868-IN21, 2012
1452012
Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion
M Björkman, P Östling, V Härmä, J Virtanen, JP Mpindi, J Rantala, T Mirtti, ...
Oncogene 31 (29), 3444-3456, 2012
1052012
Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer
R Virtakoivu, T Pellinen, JK Rantala, M Perälä, J Ivaska
Molecular biology of the cell 23 (17), 3357-3369, 2012
782012
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer
T Risom, EM Langer, MP Chapman, J Rantala, AJ Fields, C Boniface, ...
Nature communications 9 (1), 1-17, 2018
682018
A cell spot microarray method for production of high density siRNA transfection microarrays
JK Rantala, R Mäkelä, AR Aaltola, P Laasola, JP Mpindi, M Nees, ...
BMC genomics 12 (1), 1-15, 2011
662011
CDK‐mediated activation of the SCFFBXO28 ubiquitin ligase promotes MYC‐driven transcription and tumourigenesis and predicts poor survival in breast cancer
D Cepeda, HF Ng, HR Sharifi, S Mahmoudi, VS Cerrato, E Fredlund, ...
EMBO molecular medicine 5 (7), 1067-1086, 2013
572013
Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer
LL Christensen, A Holm, J Rantala, O Kallioniemi, MH Rasmussen, ...
PloS one 9 (6), e96767, 2014
562014
Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2
JK Rantala, H Edgren, L Lehtinen, M Wolf, K Kleivi, HKM Vollan, ...
Neoplasia 12 (11), 877-IN14, 2010
522010
A functional genetic screen reveals new regulators of β1-integrin activity
T Pellinen, JK Rantala, A Arjonen, JP Mpindi, O Kallioniemi, J Ivaska
Journal of cell science 125 (3), 649-661, 2012
492012
The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition
E Fredlund, J Staaf, JK Rantala, O Kallioniemi, Å Borg, M Ringnér
Breast Cancer Research 14 (4), 1-13, 2012
472012
DNA methylation and transcriptome changes associated with cisplatin resistance in ovarian cancer
RJ Lund, K Huhtinen, J Salmi, J Rantala, EV Nguyen, R Moulder, ...
Scientific reports 7 (1), 1-11, 2017
442017
Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade
H Lue, J Podolak, K Kolahi, L Cheng, S Rao, D Garg, CH Xue, JK Rantala, ...
Genes & development 31 (20), 2067-2084, 2017
382017
Distinct c-Met activation mechanisms induce cell rounding or invasion through pathways involving integrins, RhoA and HIP1
A Mai, G Muharram, R Barrow-McGee, H Baghirov, J Rantala, ...
Journal of Cell Science 127 (9), 1938-1952, 2014
332014
Oncogenic herpesvirus utilizes stress-induced cell cycle checkpoints for efficient lytic replication
G Balistreri, J Viiliäinen, M Turunen, R Diaz, L Lyly, P Pekkonen, ...
PLoS pathogens 12 (2), e1005424, 2016
242016
MHC class I loaded ligands from breast cancer cell lines: a potential HLA-I-typed antigen collection
DV Rozanov, ND Rozanov, KE Chiotti, A Reddy, PA Wilmarth, LL David, ...
Journal of proteomics 176, 13-23, 2018
202018
Personalized drug sensitivity screening for bladder cancer using conditionally reprogrammed patient-derived cells
K Kettunen, PJ Boström, T Lamminen, T Heinosalo, G West, I Saarinen, ...
European urology 76 (4), 430-434, 2019
192019
The system can't perform the operation now. Try again later.
Articles 1–20